Dr. Shirin Patel is a Schaumburg, Illinois based male Optometrist who is specialized in Optometry. Active license number of Dr. Shirin Patel is 046.010829 for Optometry in Illinois. Dr. Shirin Patel examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. He completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. He is a eye health care professional who is state-licensed to diagnose and treat diseases and disorders of the eye and visual system.
Complete Profile:
Dr. Shirin Patel speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1669889440
NPI Enumeration Date:
14 Jul, 2014
NPI Last Update On:
10 Feb, 2017
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Shirin Patel are as mentioned below.
License Number
Specialization
State
Status
046.010829
Optometry
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
350 S Western Ave, Des Plaines, Illinois
Zip:
60016
Phone Number:
312-805-5918
Fax Number:
--
Patients can reach Dr. Shirin Patel at 1 Woodfield Mall, Schaumburg, Illinois or can call to book an appointment on 847-240-0023. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.